Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Developing story — details emerging. Check the source link for the latest updates.
103 headlines
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Parabilis Medicines Inc. shares jumped as much as 67% in its trading debut, after the company raised nearly $745 million in an upsized US initial public offering that priced above its marketed range and a private placement.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.